testosterone enanthate has been researched along with Myelodysplastic Syndromes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukushima, M; Iijima, M; Koh, E; Konaka, H; Kouji, I; Maeda, Y; Mizokami, A; Namiki, M; Shigehara, K; Sugimoto, K | 1 |
| Cassano, E; Castello, A; Cazzola, M; Coci, A; Danova, M; Giordano, M; Girino, M; Montecucco, CM; Riccardi, A; Ucci, G | 1 |
2 other study(ies) available for testosterone enanthate and Myelodysplastic Syndromes
| Article | Year |
|---|---|
Myelodysplastic syndrome treated effectively with testosterone enanthate.
Topics: Aged; Androgens; Humans; Male; Methenolone; Myelodysplastic Syndromes; Testosterone; Treatment Failure | 2011 |
Refractory cytopenias: clinical course according to bone marrow cytology and cellularity.
Topics: Acute Disease; Anemia, Aplastic; Anemia, Refractory; Bone Marrow; Cell Count; Diagnosis, Differential; Female; Follow-Up Studies; Humans; Leukemia; Male; Myelodysplastic Syndromes; Testosterone; Time Factors | 1987 |